Abbott (NYSE:ABT) announced today that FDA has granted an EUA for virtually-guided, at-home use of the company’s BinaxNow COVID-19 Ag Card. Abbott has partnered with digital health provider eMed to provide telehealth-supported, at-home, prescription use of the cards, which run at $25 apiece. Similar in design to some pregnancy tests, the cards produce results within minutes […]